Key result
CMR mitral regurgitation quantification outperforms ventricular volumes in predicting symptom onset or surgical indications.
Why the study?
Does CMR quantification of mitral regurgitation predict the development of symptoms or indications for surgery better than CMR-derived ventricular volumes in patients with mitral regurgitation?
Observational
Does CMR quantification of mitral regurgitation predict the development of symptoms or indications for surgery better than CMR-derived ventricular volumes in patients with mitral regurgitation?
CMR quantification of mitral regurgitation provides superior prognostic discrimination compared to standard ventricular volumes, potentially identifying patients who would benefit from early surgery.
Answers are grounded in this paper and cite their sources.
May refine prognostication in mitral regurgitation; leaves open randomized trials before guiding surgical thresholds.
CMR quantification of mitral regurgitation was associated with the development of symptoms or other indications for surgery and showed better discriminatory ability than the reference-standard CMR-derived ventricular volumes. CMR may be able to identify appropriate patients for early surgery, with the potential to change clinical practice, although the clinical benefits of early surgery require confirmation in a clinical trial.
No takes yet. Share an insight, caveat, or question.
Myerson et al. (2016) conducted an observational in Mitral regurgitation. Cardiovascular magnetic resonance (CMR) quantification of mitral regurgitation vs. Reference-standard CMR-derived ventricular volumes was evaluated on Development of symptoms or other indications for surgery. CMR quantification of mitral regurgitation was associated with symptom development or surgical indications, showing better discrimination than CMR-derived ventricular volumes.
Synapse has enriched 10 related papers. Consider them for comparative context: